为您找到相关结果约500个

你是不是要搜索 期刊难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？ 点击跳转

Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-Ttreatment in B-ALL

Successful Anti-CD 19 CAR-T Cell Therapy in Jehovah Witness Patient with Relapsed Refractory B-ALL

Late Events After CD-19 CAR-T Treatment

Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis

Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure inaggressive B-NHL

CAR T-Cells for Cure in Pediatric B-ALL

Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of primeCAR-T

CAR T-cells for relapsed B-cell ALL in adults

Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL

Functional diversification and dynamics of CAR-T cells in patients with B-ALL

Are CAR T cells better than antibody or HCT therapy in B-ALL?

CAR T cell therapy efficacious against B-ALL across age groups

CAR-T therapy as a consolidation in remission B-ALL patients with poor prognosis

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy

Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss

为您找到相关结果约500个

共500条页码: 1/34页15条/页